Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Federal Trade Commission v. Actavis, Inc. and reverse-payment or pay-for-delay settlements

Nature Biotechnology volume 31, pages 316–317 (2013)Cite this article

Subjects

An imminent US Supreme Court ruling should resolve one of the thorniest legal issues facing pharmaceutical companies today.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ark. Carpenters Health & Welfare Fund v. Bayer AG, 625 F.3d 779, 791 (2d Cir. 2010).

  2. Elhauge, E. & Krueger, A. Tex. Law Rev. 91, 283–330 (2012).

    Google Scholar 

  3. Reiffen, D. & Ward, M.R., Rev. Econ. Stat. 87, 37–49 (2005).

    Article  Google Scholar 

  4. Petr.'s Br., FTC v. Actavis, Inc. (2013) (No. 12-1416).

  5. Br. of 118 Law, Economics, and Business Professors, and the American Antitrust Institute, FTC v. Actavis, Inc. (2013) (No. 12-1416).

  6. Higgins, M.J. & Graham, S.J.H. Science 326, 370–371 (2009).

    Article  CAS  Google Scholar 

  7. Br. of Henry A. Waxman, FTC v. Actavis, Inc. (2013) (No. 12-1416).

Download references

Author information

Authors and Affiliations

  1. Jacob S. Sherkow is a fellow at the Center for Law and the Biosciences at Stanford Law School, Stanford, California, USA.,

    Jacob S Sherkow

Authors
  1. Jacob S Sherkow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob S Sherkow.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherkow, J. Federal Trade Commission v. Actavis, Inc. and reverse-payment or pay-for-delay settlements. Nat Biotechnol 31, 316–317 (2013). https://doi.org/10.1038/nbt.2542

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2542

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing